rejuvant life tabs

New initiative offers boost for health innovators

Latest articles

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

New research institute focuses on science of aging

New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community. UC...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...
Rejuvant

A new health tech accelerator aims to support small businesses and enterprises in the fight against the aging process.

The UK’s Industrial Strategy Challenge Fund has selected three investment partners as part of a programme to promote new healthy aging solutions. Barclays Ventures, Legal and General and Northstar Ventures will all take part in the Healthy Aging Investment Accelerator, a five-year initiative to support smaller tech companies who are working to combat health issues related to the aging process.

Longevity.Technology: The Government is a great believer in the role technology can play in improving healthcare in the UK. However, many innovative companies lack the scale to bring real innovation to market. This challenge aims to inject the required capital to help some of the most promising businesses bring their innovations to market.

Working in partnership with UK Research & Innovation (UKRI), L&G, Barclays and Northstar will distribute grants to small and medium sized enterprises as well as social enterprises which are delivering innovative health tech solutions. The three funders will top-up the grant with their own capital, with the potential for further investment when the businesses start to show positive improvement [1].

L&G intends to invest the capital in up to six businesses which are producing innovative solutions to reduce health issues and the cost of care related to the aging process. Over a five-year period, they aim to commit a total £24 million.


 

“We are seeing abundant opportunities emerge in ‘age-tech’ as businesses rise to the challenge of helping people live longer, happier and healthier lives – a mission we fully support.”

 


 

Legal and General has a healthy track record of investing alongside the UKRI in opportunities across prop tech, clean tech, fintech and health tech. So far it has invested £22bn directly into UK businesses assisting them to scale up. It also recently acquired a minority shareholding in Current Health, an AI powered remote patient tracking platform which is helping to monitor and manage Covid 19 patients in their own home to boost hospital capacity.

Elevant

Barclays and Northstar Ventures will also be supporting early stage companies specialising in healthtech whose objectives align with the Healthy Aging Challenge. UKRI will match investments from the three funds with a non-payable grant to successful businesses. This, the organisation says, represents direct public money going into growing high-tech businesses which are working to improve health outcomes in the UK [2].

The call is currently out for businesses or social enterprises working in the health tech sector with the official launch date of 11th June.

Elevant

[1] https://bit.ly/3g7iqep

[2] https://labs.uk.barclays/healthtech/healthy-ageing

 

Carla Heyworth
Carla is sub editor at Longevity.Technology and she's the glue that keeps the team on track and the articles rolling-out. She has an extensive background in B2B communications, events and marketing. Carla's a visual person and can often be found behind a camera or editing photos
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

New research institute focuses on science of aging

New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community. UC...

Call for £3b intervention to save lives and back health

"Levelling Up Health" Ten Year Plan would save 40,000 lives from next pandemic says cross party group, as it calls for £3 billion intervention...

Juvenescence appoints Chief Scientific Officer

Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer. Juvenescence Ltd, a life sciences company focused on modifying...
Supps report ad middle